391 results match your criteria: "and St. Louis Children's Hospital[Affiliation]"

Article Synopsis
  • Pediatrics is a dynamic field where clinicians can develop research to enhance evidence-based practices, yet they often find it challenging to juggle both education and clinical care.
  • New faculty members face particular difficulties in initiating their first research projects due to limited experience, resources, and team development.
  • The manuscript provides 10 key reflections to help newcomers navigate their first research projects and build a strong foundation to prevent common mistakes.
View Article and Find Full Text PDF

Background: Surgery for knee flexion contractures in patients with arthrogryposis multiplex congenital (AMC) have achieved extension to redirect the arc of motion and improve ambulation but has not demonstrated maintained increases in total range of motion (ROM). This study aimed to review the clinical outcomes of combined posterior knee release, proximal femoral shortening, and nerve decompression in patients with arthrogryposis.

Methods: A retrospective chart and radiographic review were performed on patients with AMC who underwent treatment for knee flexion deformities ≥30 degrees.

View Article and Find Full Text PDF

Microvascular Inflammation of Kidney Allografts and Clinical Outcomes.

N Engl J Med

October 2024

From Université Paris Cité, INSERM Unité 970, Paris Institute for Transplantation and Organ Regeneration (M.S., A.S., M. Raynaud, V.G., G.D., D.Y., J.H., C. Legendre, O.A., C. Lefaucheur, A.L.), the Department of Pathology, Bichat Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) (A.S.), the Kidney Transplant Department (G.D., C. Lefaucheur) and the Department of Pathology (J. Verine), Saint-Louis Hospital, AP-HP, the Department of Pathology, Necker Hospital, AP-HP (M. Rabant), the Division of Pediatric Nephrology, Necker Hospital, AP-HP, Université Paris Cité (O. Boyer), the Department of Kidney Transplantation, Necker Hospital, AP-HP (M.T., C. Legendre, D.A., O.A., A.L.), and the Division of Pediatric Nephrology, Robert Debré Hospital, AP-HP (J.H.), Paris, the Departments of Pediatric Nephrology (M.F.) and Nephrology (M.L.Q.), Centre Hospitalier Universitaire (CHU) Montpellier, Montpellier, the Pediatric Nephrology Department, Hôpital Universitaire Mère-Enfant, Hospices Civils de Lyon (HCL) (A.-L.S.-L.), and the Department of Transplantation, Edouard Herriot University Hospital, HCL, University of Lyon I (E.M.), Lyon, the Department of Nephrology-Dialysis-Transplantation, CHU de Toulouse, Toulouse (A.B., N.K.), Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, Unité Mixte de Recherche 1064, Institute of Urology-Nephrology Transplantation of the University Hospital of Nantes, Nantes (R.D., M.G., P.-A.G., S.B.), and the Departments of Pathology (B.C.) and Nephrology, Transplantation, Dialysis, and Apheresis (L.C.), CHU Bordeaux, Bordeaux - all in France; the Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health (B.C.A.), and the Department of Pathology, University of Wisconsin (A.A., W.Z.) - both in Madison; Pediatric Nephrology, David Geffen School of Medicine at UCLA, UCLA Mattel Children's Hospital (P.W.), and Cedars-Sinai Comprehensive Transplant Center (E.H.) - both in Los Angeles; the Department of Pediatrics, University of Washington School of Medicine, Seattle Children's Hospital, Seattle (J.S.); the Division of Pediatric Nephrology, Emory University School of Medicine, Children's Pediatric Institute, Atlanta (R.G.); the Division of Pediatric Nephrology, University of Kansas City, Children's Mercy Hospital, Kansas City, MO (B.A.W.); the Division of Pediatric Nephrology and Hypertension, University of Tennessee Health Science Center, Le Bonheur Children's Hospital, Memphis (R.S.Z.); the Acute Dialysis Units, Pediatric Kidney Transplant, Medical University of South Carolina, Charleston (K.T.); the Division of Pediatric Nephrology, Hypertension, and Apheresis, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis (V.R.D., R.S.D.); the Department of Pediatrics, Robert Wood Johnson Medical School at Rutgers University, New Brunswick, NJ (V.R.D.); the Department of Pediatrics I, University Children Hospital Heidelberg, Heidelberg (B.T.), and the Department of Nephrology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Berlin Institute of Health, Berlin (R.A.C., K.B.) - both in Germany; the Division of Abdominal and Transplantation Surgery, Department of Surgery, Faculty of Medicine, Geneva University Hospitals (T.B.), and the Division of Transplantation Immunology, University Hospital of Geneva (J. Villard), Geneva, and the Division of Clinical Pharmacology, Department of Medicine, and the Department of Laboratory Medicine and Pathology, Lausanne University Hospital, Faculty of Medicine, University of Lausanne, Lausanne (F.R.G.) - all in Switzerland; and the Department of Nephrology and Kidney Transplantation, Vall d'Hebrón University Hospital, Barcelona (O. Bestard).

Background: The heterogeneous clinical presentation of graft microvascular inflammation poses a major challenge to successful kidney transplantation. The effect of microvascular inflammation on allograft outcomes is unclear.

Methods: We conducted a cohort study that included kidney-transplant recipients from more than 30 transplantation centers in Europe and North America who had undergone allograft biopsy between 2004 and 2023.

View Article and Find Full Text PDF

Background: Understanding of multisystem inflammatory syndrome in children (MIS-C) continues to evolve with extensive evaluations, including echocardiograms, obtained in emergency departments (EDs) to assist with clinical decision making and bed allocation. We assessed the utility of obtaining echocardiograms in the ED to assist in determining bed placement for this patient population.

Methods: This 2-year retrospective single-center study of patients 0-21 years old without underlying cardiac disease hospitalized for MIS-C focused on individuals whose initial evaluation occurred in the institution's ED and whose echocardiogram was obtained either in the ED or within 24 hours of admission.

View Article and Find Full Text PDF

Analysis of Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society.

Neurology

September 2024

From the Department of Neurology (J.M.M.), Wake Forest University School of Medicine, Winston-Salem, NC; Providence Health and Services (A.L.C.), OR; Department of Pediatrics (G.Y.G.), Emory University School of Medicine, Children's Healthcare of Atlanta, GA; Department of Neurology (B.R.A.), School of Medicine, Washington University in St Louis and St Louis Children's Hospital, MO; Department of Neurology (L.J.), University of Virginia, Charlottesville; Division of Pediatric Neurology (S.J.), Department of Pediatrics, University of Michigan, Ann Arbor; Department of Neurology (J.B.S.), University of California, San Francisco; Child Neurology Society (M.T.), Minneapolis, MN; LSU Health Sciences Center and Children's Hospital New Orleans (A.H.T.), LA; Department of Neurology (P.L.P.), Harvard Medical School, Boston, MA; Department of Physical Medicine and Rehabilitation (J.K.S.), Harvard Medical School; Spaulding Rehabilitation Hospital (J.K.S.); Massachusetts General Hospital (J.K.S.); Brigham and Women's Hospital (J.K.S.), Boston, MA; Pittsford, NY (J.W.M.); and Division of Child Neurology (Y.K.), Departments of Pediatrics and Neurology, Memorial Sloan Kettering Cancer Center, New York, NY.

Article Synopsis
  • The study investigates gender representation in leadership positions and award recipients within the Child Neurology Society (CNS) over a 50-year period, from 1972 to 2023.
  • Despite women making up the majority of child neurology trainees since 2007, they hold only 29% of board positions and 26% of post-training awards, indicating a persistent gender gap.
  • While the number of women in nonpresidential roles has increased, only 13% of CNS presidents have been women, highlighting significant underrepresentation in top leadership positions.
View Article and Find Full Text PDF

White matter injury (WMI) is thought to be a major contributor to long-term cognitive dysfunctions after traumatic brain injury (TBI). This damage occurs partly due to apoptotic death of oligodendrocyte lineage cells (OLCs) after the injury, triggered directly by the trauma or in response to degenerating axons. Recent research suggests that the gut microbiota modulates the inflammatory response through the regulation of peripheral immune cell infiltration after TBI.

View Article and Find Full Text PDF

Background: Recurrence of focal segmental glomerulosclerosis (FSGS) or steroid-resistant nephrotic syndrome (SRNS) after kidney transplant leads to significant morbidity and potentially earlier allograft loss. To date however, reported rates, risk factors and treatment outcomes have varied widely.

Methods: We applied computational phenotypes to a multicenter aggregation of electronic health records data from 7 large pediatric health systems in the USA, to identify recurrence rates, risk factors, and treatment outcomes.

View Article and Find Full Text PDF

Using a new analytic method ("unique non-overlapping region" (UNOR) analysis), we characterized the genotypes and phenotypes of a large cohort of individuals diagnosed with chromosome 9p deletion syndrome (9PMS) and defined critical genomic regions. We extracted phenotypic information from 48 individuals with 9PMS from medical records and used a guided interview with caregivers to clarify ambiguities. Using high-resolution whole-genome sequencing for breakpoint definition, we aligned deletions and drew virtual breakpoints to obtain UNORs associated with phenotypic characteristics.

View Article and Find Full Text PDF

Central nervous system (CNS) injury is common in sickle cell disease (SCD) and occurs early in life. Hydroxyurea is safe and efficacious for treatment of SCD, but high-quality evidence from randomized trials to estimate its neuroprotective effect is scant. HU Prevent was a randomized (1:1), double-blind, phase II feasibility/pilot trial of dose-escalated hydroxyurea vs.

View Article and Find Full Text PDF

Evolving understanding of CP phenotypes: the importance of dystonia.

Pediatr Res

June 2024

Departments of Cellular & Molecular Medicine, Child Health, and Neurology and Program in Genetics, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA.

Article Synopsis
  • Cerebral palsy (CP) is a major neurodevelopmental disorder that affects movement, with dystonia being a common and serious movement disorder associated with it.
  • Dystonia involves abnormal, often repetitive, twisting movements and can lead to chronic pain and hospitalizations in CP patients.
  • Recent advances in diagnosing dystonia in CP have been made, emphasizing the need for tailored treatment approaches and further research to improve care for these individuals.
View Article and Find Full Text PDF

Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities.

Genet Med

September 2024

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX. Electronic address:

Article Synopsis
  • * Through analysis of fibroblasts and a fruit fly model, we found that these variants resulted in decreased lipid droplet formation and impaired gene expression linked to SREBP, indicating disrupted pathway function.
  • * Our findings suggest that SREBF2 variants hinder the cleavage of S1P targets, causing disease symptoms by negatively affecting SREBP1 and SREBP2 activity.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the outcomes of neonates with symptomatic tetralogy of Fallot (TOF) based on whether they had a ductus arteriosus (DA) or absent DA (ADA).
  • Researchers conducted a retrospective multi-center study involving 519 neonates to assess the risks of death and need for reintervention, focusing on ADA and critically deficient pulmonary blood flow (CDPBF).
  • Findings indicated that neonates with ADA faced a significantly higher mortality risk compared to those with DA, highlighting the rare but critical nature of CDPBF among these patients.
View Article and Find Full Text PDF
Article Synopsis
  • * Strong recommendations include reducing immunosuppression as an initial management step and using the anti-CD20 monoclonal antibody (rituximab), as well as chemotherapy in specific cases.
  • * There is a lack of large randomized phase III trials for treating PTLD in pediatrics, leading to reliance on clinical experience, and the report emphasizes the need for future research on this topic.
View Article and Find Full Text PDF

Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy.

J Neuromuscul Dis

May 2024

Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA; The Ohio State University, Columbus, OH, USA.

Background: Duchenne muscular dystrophy (DMD) is a rare, degenerative, recessive X-linked neuromuscular disease. Mutations in the gene encoding dystrophin lead to the absence of functional dystrophin protein. Individuals living with DMD exhibit progressive muscle weakness resulting in loss of ambulation and limb function, respiratory insufficiency, and cardiomyopathy, with multiorgan involvement.

View Article and Find Full Text PDF

Single ventricular assist device (SVAD) use before and after stage I palliation (S1P) is increasing with limited data on outcomes. To address this knowledge gap, we conducted a single-center retrospective review to assess pre- and post-SVAD clinical status, complications, and outcomes. We leveraged a granular, longitudinal, local database that captures end-organ support, procedural interventions, hematologic events, laboratory data, and antithrombotic strategy.

View Article and Find Full Text PDF
Article Synopsis
  • Mutations in ABCA3, a crucial transporter for lung surfactant balance, are the leading genetic cause of childhood interstitial lung disease (chILD), but effective treatments are limited due to a lack of understanding of how these mutations cause disease.
  • Researchers generated induced pluripotent stem cells (iPSCs) from affected patients with ABCA3 mutations to create alveolar type II epithelial cells (AEC2s) for in vitro modeling, which revealed decreased surfactant secretion and unexpected abnormal characteristics in mutant cells.
  • Using ABCA3:GFP fusion reporters, the study quantified how different ABCA3 mutations affect lamellar body size and protein trafficking, providing insights into the
View Article and Find Full Text PDF

Noninvasive management of infants with SFTPC pathogenic variants.

Pediatr Pulmonol

February 2024

Department of Pediatrics, Section of Pulmonary and Sleep Medicine, University of Colorado, School of Medicine, Aurora, Colorado, USA.

View Article and Find Full Text PDF

Background: Invasive infections caused by (invasive group A streptococcus [iGAS]) and (invasive pneumococcal disease [IPD]) decreased substantially at the beginning of the COVID-19 pandemic. Our study sought to evaluate the extent of this decrease and the trends of these infections since reversion of societal adjustments incident to the pandemic. We also wanted to compare the frequency of these infections with invasive community-onset (I-CO-SA) infections and common respiratory viral infections in this period.

View Article and Find Full Text PDF

Background: Dystonia in cerebral palsy (CP) is classically associated with deep gray matter injury at term gestation, but the patterns of injury associated with dystonia following premature birth are unclear. We examined whether there were brain regional size differences associated with dystonia in people with CP born premature.

Methods: In this retrospective cohort study, we identified subjects with CP born premature (<37 weeks gestational age) seen at a tertiary care CP center between February 1, 2017, to February 1, 2021, who had T1-weighted brain magnetic resonance imaging (MRI) done between ages one and five years available in the clinical record.

View Article and Find Full Text PDF

Pulmonary Artery Hypoplasia in Neonates With Tetralogy of Fallot.

J Am Coll Cardiol

August 2023

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Article Synopsis
  • - The study analyzed neonates with symptomatic tetralogy of Fallot (sTOF) to examine how hypoplastic pulmonary arteries (hPA) impact survival and treatment outcomes, reviewing data from 2005 to 2017 on 542 cases.
  • - Results showed that while reintervention was more common in the hPA group, survival rates and mortality did not differ significantly between those with hPA and those with normal pulmonary arteries.
  • - Notably, the hPA cohort experienced better pulmonary artery growth after one year, suggesting that having hPA does not negatively affect the overall outcomes for neonates with sTOF.
View Article and Find Full Text PDF

Background: Among individuals with sickle cell disease (SCD), decreased hemoglobin is associated with lower oxygen saturation (SpO2) and increased risk of stroke, both of which are associated with lower intelligence quotient (IQ) scores. Thus, increasing hemoglobin and SpO2 in individuals with SCD may increase IQ and educational attainment.

Methods: A cohort simulation model was built to determine academic performance and educational attainment based on cognitive function (measured by IQ) of a pediatric SCD cohort randomly assigned to treatment and control groups.

View Article and Find Full Text PDF

Objective: Clinicians report low confidence assessing cutaneous lupus erythematosus (CLE) lesions, especially for patients who identify as Black, Indigenous, and People of Color (BIPOC) who are historically excluded from educational materials. To address this, we created an online, interactive module teaching an approach to assessing CLE across skin tones and measured its impact on medical knowledge and confidence.

Methods: Our team created a module with case-based methods to introduce an approach to CLE, common mimicking rashes, and tips for photographing cutaneous lesions in BIPOC.

View Article and Find Full Text PDF

Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is a lethal developmental disorder of lung morphogenesis caused by insufficiency of FOXF1 (forkhead box F1) transcription factor function. The cellular and transcriptional mechanisms by which FOXF1 deficiency disrupts human lung formation are unknown. To identify cell types, gene networks, and cell-cell interactions underlying the pathogenesis of ACDMPV.

View Article and Find Full Text PDF

Provision and availability of genomic medicine services in Level IV neonatal intensive care units.

Genet Med

October 2023

Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH; Divisions of Neonatology and Genetics and Genomic Medicine, Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH.

Purpose: To describe variation in genomic medicine services across level IV neonatal intensive care units (NICUs) in the United States and Canada.

Methods: We developed and distributed a novel survey to the 43 level IV NICUs belonging to the Children's Hospitals Neonatal Consortium, requesting a single response per site from a clinician with knowledge of the provision of genomic medicine services.

Results: Overall response rate was 74% (32/43).

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the safety of intravenous lacosamide (LCM) in treating seizures in 686 children and 28 neonates over more than a decade.
  • Adverse events linked to LCM were rare, occurring in only 1.5% of children, while no adverse events were reported in neonates, indicating a high safety profile.
  • However, children receiving a higher-than-recommended initial dose faced a doubled risk of developing a rash, underlining the importance of adhering to dosage guidelines.
View Article and Find Full Text PDF